MML Investors Services
XBI icon

MML Investors Services’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

MML Investors Services’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.7M Buy
48,660
+17,594
+57% +$2.38M 0.02% 762
2026
Q1 		$3.97M Buy
31,066
+5,439
+21% +$679K 0.01% 934
2025
Q4 		$3.12M Buy
25,627
+3,220
+14% +$369K 0.01% 1132
2025
Q3 		$2.25M Sell
22,407
-2,550
-10% -$230K 0.01% 1262
2025
Q2 		$2.07M Sell
24,957
-1,285
-5% -$103K 0.01% 1229
2025
Q1 		$2.13M Sell
26,242
-27,028
-51% -$2.42M 0.01% 1144
2024
Q4 		$4.8M Sell
53,270
-47
-0.1% -$4.55K 0.02% 729
2024
Q3 		$5.27M Sell
53,317
-1,808
-3% -$178K 0.02% 657
2024
Q2 		$5.11M Buy
55,125
+297
+0.5% +$26.6K 0.02% 624
2024
Q1 		$5.2M Sell
54,828
-3,886
-7% -$361K 0.02% 623
2023
Q4 		$5.24M Sell
58,714
-86,710
-60% -$6.44M 0.02% 576
2023
Q3 		$10.6M Buy
145,424
+6,528
+5% +$521K 0.06% 319
2023
Q2 		$11.6M Sell
138,896
-3,928
-3% -$328K 0.06% 295
2023
Q1 		$10.9M Buy
142,824
+27,101
+23% +$2.25M 0.08% 263
2022
Q4 		$9.61M Buy
115,723
+31,387
+37% +$2.54M 0.06% 312
2022
Q3 		$6.69M Buy
84,336
+4,544
+6% +$383K 0.05% 353
2022
Q2 		$5.93M Sell
79,792
-10,392
-12% -$780K 0.05% 374
2022
Q1 		$8.11M Sell
90,184
-24,384
-21% -$2.25M 0.06% 321
2021
Q4 		$12.8M Buy
114,568
+18,292
+19% +$2.21M 0.09% 229
2021
Q3 		$12.1M Buy
96,276
+11,398
+13% +$1.47M 0.1% 233
2021
Q2 		$11.5M Buy
84,878
+21,921
+35% +$2.88M 0.1% 229
2021
Q1 		$8.54M Buy
62,957
+15,307
+32% +$2.29M 0.08% 250
2020
Q4 		$6.71M Sell
47,650
-11,156
-19% -$1.43M 0.07% 262
2020
Q3 		$6.55M Sell
58,806
-5,119
-8% -$574K 0.08% 230
2020
Q2 		$7.16M Sell
63,925
-4,904
-7% -$483K 0.1% 217
2020
Q1 		$5.33M Buy
68,829
+7,723
+13% +$684K 0.09% 221
2019
Q4 		$5.81M Sell
61,106
-35,497
-37% -$3.07M 0.08% 238
2019
Q3 		$7.37M Buy
96,603
+11,726
+14% +$975K 0.12% 191
2019
Q2 		$7.45M Buy
84,877
+20,445
+32% +$1.74M 0.11% 210
2019
Q1 		$5.83M Buy
64,432
+3,261
+5% +$277K 0.09% 229
2018
Q4 		$4.39M Buy
61,171
+14,466
+31% +$1.17M 0.08% 260
2018
Q3 		$4.48M Buy
46,705
+6,135
+15% +$595K 0.08% 251
2018
Q2 		$3.86M Buy
40,570
+2,499
+7% +$230K 0.08% 232
2018
Q1 		$3.34M Buy
38,071
+1,517
+4% +$138K 0.07% 249
2017
Q4 		$3.1M Buy
36,554
+12,803
+54% +$1.07M 0.06% 256
2017
Q3 		$2.06M Buy
23,751
+1,168
+5% +$93.6K 0.04% 326
2017
Q2 		$1.74M Buy
+22,583
New +$1.6M 0.03% 356

Other funds holding XBI

Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return
MSR
Main Street Research Lakeville, Connecticut $2.12B AUM 67.44% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
WT
Whittier Trust South Pasadena, California $10.2B AUM 33.39% 1-Year Est. Return

MML Investors Services's XBI Position: Q2 2026 in Review

MML Investors Services increased its State Street SPDR S&P Biotech ETF (XBI) stake by 57% in Q2 2026, buying an estimated $2.38M and bringing the position to 48,660 shares worth $7.7M. The position accounts for 0.02% of the portfolio, ranked #762.

MML Investors Services first reported a position in XBI in Q2 2017 and has held it in 37 quarters since. The position peaked at $12.8M in Q4 2021. 564 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • MML Investors Services held 48,660 shares of State Street SPDR S&P Biotech ETF worth $7.7M as of Q2 2026.
  • MML Investors Services bought 17,594 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $2.38M.
  • State Street SPDR S&P Biotech ETF made up 0.02% of MML Investors Services's portfolio in Q2 2026, its #762 holding.
  • MML Investors Services first reported a position in State Street SPDR S&P Biotech ETF in Q2 2017 and has held it in 37 quarters since.
  • MML Investors Services's State Street SPDR S&P Biotech ETF position peaked at $12.8M in Q4 2021.
  • 564 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.